Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
JVV-Pharma Oy
OY
Active
Y-tunnus 3087608-9
Puntarikatu 3, 20780
Kaarina
Retail sale of medical and orthopaedic goods
·
NACE 4774
Est. 2019 · 6 years old
— employees
Share
Finland
/
Companies
/
Retail sale of medical and orthopaedic goods
/
JVV-Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
1 225
1 215
1 214
1 201
603
Staff expenses
−0
−0
−0
—
—
EBITDA
407
374
358
351
170
Depreciation & amort.
−18
−32
−33
—
—
EBIT
389
342
325
351
170
Net financials
0
2
2
0
0
Profit before tax
390
344
326
351
170
Tax
78
69
65
70
34
Net profit
312
275
261
281
136
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
1 242
1 000
799
583
296
Equity
1 197
962
747
528
269
Long-term debt
0
0
0
—
—
Short-term debt
46
38
52
54
27
Total debt
46
38
52
54
27
Financial ratios
5-year trend
EBITDA margin
33,2 %
This company
15,8 %
Market median
This company
Market median
110% above market
2021
2025
Equity ratio
96,3 %
This company
38,2 %
Market median
This company
Market median
152% above market
2021
2025
Return on equity
26,0 %
This company
18,4 %
Market median
This company
Market median
41% above market
2021
2025
Net profit margin
25,4 %
This company
8,1 %
Market median
This company
Market median
214% above market
2021
2025
Asset turnover
0,99×
This company
1,12×
Market median
This company
Market median
12% below market
2021
2025
Debt / equity
0,04×
This company
0,62×
Market median
This company
Market median
94% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on JVV-Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
